Results 241 to 250 of about 469,048 (336)
Comorbidity and risk of cardiac events in patients with acute coronary syndrome
Roman Komorovsky
openalex +1 more source
ABSTRACT Diabetic cardiomyopathy (DCM) is a common complication of diabetes mellitus. This study investigated the effects of alogliptin on DCM and its underlying mechanisms. A DCM model was constructed and treated with alogliptin. Downstream targets of alogliptin were screened using bioinformatics analysis.
Li‐Jing Jiao +7 more
wiley +1 more source
A study of extended lipid profile in patients with acute coronary syndrome: Focus on Lipoprotein(a) and PCSK9. [PDF]
Kumar P +12 more
europepmc +1 more source
Kounis syndrome: allergic acute coronary syndrome
Min, Xu +3 more
openaire +2 more sources
Metabolic Dysfunction‐Associated Steatotic Liver Disease After Hepatitis C Virus Cure
ABSTRACT Hepatitis C virus (HCV) infection is an infectious disease carrying a high risk of metabolic disorders. Chronic HCV (CHC) patients can possess extrahepatic manifestations such as diabetes, steatotic liver disease (SLD), and other metabolic alterations.
Chung‐Feng Huang +3 more
wiley +1 more source
Comparison of Pretreatment in European Society of Cardiology Acute Coronary Syndrome Guidelines. [PDF]
Ataş İ +6 more
europepmc +1 more source
Movement Disorders in Neuromyelitis Optica Spectrum Disorder: A Systematic Review
Abstract Background Several movement disorders (MD) have been reported to occur in neuromyelitis optica spectrum disorder (NMOSD). No extensive review has addressed the whole spectrum of MD in NMOSD. Objective This article aims to review MD in NMOSD, describing its prevalence and features.
Luciana A.F. Bringel +18 more
wiley +1 more source
Naples Prognostic Score and Clinical Outcomes After PCI for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis. [PDF]
Özen Y +8 more
europepmc +1 more source
Human Cyclophilins—An Emerging Class of Drug Targets
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova +3 more
wiley +1 more source

